ClinicalTrials.Veeva

Menu

Thoracoscopic Sympathectomy for Blushing

O

Odense University Hospital

Status and phase

Completed
Phase 4

Conditions

Facial Blushing

Treatments

Procedure: Level of sympathectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT00225069
TOPSY1-2005

Details and patient eligibility

About

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.

Full description

To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery

Enrollment

100 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Isolated disabling facial blushing
  • Over 18 years of age
  • Willing to be randomized

Exclusion criteria

  • Primary hyperhidrosis in palms or axillae
  • Previous lung surgery
  • Bradycardia
  • Arrythmias
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

100 participants in 2 patient groups

1
Experimental group
Description:
T2 sympathectomy
Treatment:
Procedure: Level of sympathectomy
2
Experimental group
Description:
T2-T3 sympathectomy
Treatment:
Procedure: Level of sympathectomy

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems